These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 26363110)
21. Cloning and expression of hybrid streptokinase towards clot-specific activity. Buniya HK; Murugan V; Thangadurai C J Microbiol Methods; 2014 Mar; 98():84-8. PubMed ID: 24440164 [TBL] [Abstract][Full Text] [Related]
22. Improving antiproliferative effect of the anticancer drug cytarabine on human promyelocytic leukemia cells by coating on Fe3O4@SiO2 nanoparticles. Shahabadi N; Falsafi M; Mansouri K Colloids Surf B Biointerfaces; 2016 May; 141():213-222. PubMed ID: 26852105 [TBL] [Abstract][Full Text] [Related]
23. Synergistic fibrinolysis: The combined effects of tissue plasminogen activator and recombinant staphylokinase in vitro. Aisina R; Mukhametova L; Varfolomeyev S Biochim Biophys Acta; 2016 Apr; 1860(4):629-35. PubMed ID: 26723174 [TBL] [Abstract][Full Text] [Related]
24. Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes. Tiukinhoy-Laing SD; Huang S; Klegerman M; Holland CK; McPherson DD Thromb Res; 2007; 119(6):777-84. PubMed ID: 16887172 [TBL] [Abstract][Full Text] [Related]
25. Fibrinolytic profiles in local low-dose thrombolysis with streptokinase and recombinant tissue plasminogen activator. Berridge DC; Earnshaw JJ; Westby JC; Makin GS; Hopkinson BR Thromb Haemost; 1989 Apr; 61(2):275-8. PubMed ID: 2501898 [TBL] [Abstract][Full Text] [Related]
28. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction. Parise P; Hauert J; Iorio A; Callegari P; Agnelli G J Lab Clin Med; 1995 Feb; 125(2):212-21. PubMed ID: 7531212 [TBL] [Abstract][Full Text] [Related]
29. [Thrombolytic treatment in acute myocardial infarction. Choice of preparations in Norwegian hospitals]. Andreassen AK; Gullestad L; Endresen K Tidsskr Nor Laegeforen; 1998 Jun; 118(17):2630-1. PubMed ID: 9673511 [TBL] [Abstract][Full Text] [Related]
30. Thrombolytic therapy with streptokinase and tissue plasminogen activator in a patient with suspected acute myocardial infarction: A decision analysis. Hiatt MD Cardiology; 1999; 91(4):243-9. PubMed ID: 10545680 [TBL] [Abstract][Full Text] [Related]
31. The use of magnetite nanoparticles for implant-assisted magnetic drug targeting in thrombolytic therapy. Kempe M; Kempe H; Snowball I; Wallén R; Arza CR; Götberg M; Olsson T Biomaterials; 2010 Dec; 31(36):9499-510. PubMed ID: 20732712 [TBL] [Abstract][Full Text] [Related]
32. Synthesis of Functionalized Magnetic Nanoparticles, Their Conjugation with the Siderophore Feroxamine and its Evaluation for Bacteria Detection. Martínez-Matamoros D; Castro-García S; Ojeda Romano G; Balado M; Rodríguez J; Lemos ML; Jiménez C J Vis Exp; 2020 Jun; (160):. PubMed ID: 32628159 [TBL] [Abstract][Full Text] [Related]
33. Fluorescence and magnetic nanocomposite Fe Luo S; Liu Y; Rao H; Wang Y; Wang X Anal Biochem; 2017 Dec; 538():26-33. PubMed ID: 28917502 [TBL] [Abstract][Full Text] [Related]
34. A new drug delivery system for intravenous coronary thrombolysis with thrombus targeting and stealth activity recoverable by ultrasound. Kawata H; Uesugi Y; Soeda T; Takemoto Y; Sung JH; Umaki K; Kato K; Ogiwara K; Nogami K; Ishigami K; Horii M; Uemura S; Shima M; Tabata Y; Saito Y J Am Coll Cardiol; 2012 Dec; 60(24):2550-7. PubMed ID: 23158532 [TBL] [Abstract][Full Text] [Related]
35. Preparation and characterization of anionic oligopeptide-modified tissue plasminogen activator for triggered delivery: an approach for localized thrombolysis. Absar S; Choi S; Ahsan F; Cobos E; Yang VC; Kwon YM Thromb Res; 2013 Mar; 131(3):e91-9. PubMed ID: 23269380 [TBL] [Abstract][Full Text] [Related]
37. Guidelines for the use of intravenous thrombolytic agents in acute myocardial infarction. Ontario Medical Association Consensus Group on Thrombolytic Therapy. Naylor CD; Armstrong PW CMAJ; 1989 Jun; 140(11):1289-99. PubMed ID: 2497946 [TBL] [Abstract][Full Text] [Related]
38. Affinity Based Nano-Magnetic Particles for Purification of Recombinant Proteins in Form of Inclusion Body. Seyedinkhorasani M; Ahangari Cohan R; Taghavi Fardood S; Roohvand F; Norouzian D; Keramati M Iran Biomed J; 2020 May; 24(3):192-200. PubMed ID: 31952436 [TBL] [Abstract][Full Text] [Related]
39. Comparative study of three magnetic nano-particles (FeSO4, FeSO4/SiO2, FeSO4/SiO2/TiO2) in plasmid DNA extraction. Rahnama H; Sattarzadeh A; Kazemi F; Ahmadi N; Sanjarian F; Zand Z Anal Biochem; 2016 Nov; 513():68-76. PubMed ID: 27592192 [TBL] [Abstract][Full Text] [Related]
40. Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation. Hare TR; Gardell SJ Thromb Haemost; 1992 Aug; 68(2):165-9. PubMed ID: 1412162 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]